dehydroretronecine has been researched along with pyrroles in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ciaramitaro, D; Eisenstein, D; Huxtable, R | 1 |
Hopkins, PB; Sigurdsson, ST; Weidner, MF | 1 |
Driver, HE; Mattocks, AR | 1 |
Legg, RF; Mattocks, AR | 1 |
Huxtable, RJ; Yan, CC | 1 |
5 other study(ies) available for dehydroretronecine and pyrroles
Article | Year |
---|---|
The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium.
Topics: Adenosine Monophosphate; Animals; Blood Pressure; Endothelium; Heart; In Vitro Techniques; Leucine; Lung; Male; Monocrotaline; Norepinephrine; Organ Size; Plants, Toxic; Pyrroles; Pyrrolizidine Alkaloids; Rats; Senecio; Serotonin; Time Factors; Tissue Distribution | 1978 |
Sequence preferences of DNA interstrand cross-linking agents: dG-to-dG cross-linking at 5'-CG by structurally simplified analogues of mitomycin C.
Topics: Base Sequence; Cross-Linking Reagents; DNA; Mitomycin; Mitomycins; Molecular Sequence Data; Monocrotaline; Nucleic Acid Conformation; Pyrroles; Pyrrolizidine Alkaloids | 1990 |
A comparison of the pneumotoxicity of some pyrrolic esters and similar compounds analogous to pyrrolizidine alkaloid metabolites, given intravenously to rats.
Topics: Animals; Female; Injections, Intravenous; Liver; Lung; Male; Monocrotaline; Pyrroles; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1983 |
Antimitotic activity of dehydroretronecine, a pyrrolizidine alkaloid metabolite, and some analogous compounds, in a rat liver parenchymal cell line.
Topics: Animals; Cell Line; Cell Survival; Liver; Mitosis; Monocrotaline; Pyrroles; Pyrrolizidine Alkaloids; Rats; Structure-Activity Relationship | 1980 |
The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver.
Topics: Analysis of Variance; Animals; Bile; Carcinogens; Dose-Response Relationship, Drug; Glutathione; In Vitro Techniques; Liver; Mass Spectrometry; Monocrotaline; Perfusion; Pyrroles; Rats | 1995 |